17 Dec 2019 – APSIC guidelines recommend decolonising S. aureus

New Asian (APSIC) guidelines for prevention of surgical site infections recommend decolonisation of Staphylococcus aureus in surgical patients to prevent surgical site infections

Guidelines warn of issue of antibiotic resistance highlighting the need for new approaches

Destiny Pharma’s XF‐73, currently in Phase 2b development with data anticipated in mid‐2020, could provide rapid and effective nasal bacterial decolonisation prior to surgery

For full press release, please click here